StockMirror — Stock Screener

JLHL Q2 FY27 Results & Earnings Analysis

Sentiment: Good (Confidence: medium)

Earnings Summary

Jupiter Life Line Hospitals reported Q2 FY27 income of INR456.5 cr, EBITDA of INR106.9 cr, and PAT of INR56.4 cr; H1 income INR867.5 cr, EBITDA INR186.2 cr, PAT INR93.9 cr . Key highlight was Dombivli hospital nearing EBITDA breakeven (INR0.2 cr loss vs INR9.5 cr in Q1), though partly aided by seasonal infectious disease benefit . The company acquired Pune South land for INR150 cr and has three projects in progress (Pune South, Mira Bhayandar, BKC) . Management refrained from providing financial guidance . Regulatory risks from Supreme Court scrutiny on healthcare pricing and oncology drug margin cap remain unquantified . Debt ceiling of 3x EBITDA provides financial discipline .

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management is investing in growth through new hospitals (Pune South, Mira Bhayandar, BKC) and bed additions while maintaining focus on profitability via 3x EBITDA debt ceiling and 2-year EBITDA breakeven targets for new hospitals . Dombivli achieving near-breakeven ahead of schedule demonstrates ba

About Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited (JLHL) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More